Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04114435

Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants

Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants: A Prospective Cross-sectional Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
Sex
All
Age
7 Days – 5 Years
Healthy volunteers
Accepted

Summary

Pulmonary vascular disease and cardiac performance in extreme preterm infants: A prospective cross-sectional study

Detailed description

The principal investigator hypothesize that premature newborns have disturbed cardiac performance and increased pulmonary pressures during neonatal life and at different pediatric ages. The principal investigator also hypothesize that premature newborns with poor cardiac performance and/or pulmonary hypertension have higher morbidities and poorer neuro-developmental outcomes. The principal investigator also hypothesize that premature newborns with poor cardiac performance and/or pulmonary hypertension have higher morbidities and poorer neuro-developmental outcomes and that novel echocardiography techniques will detect anomalies not uncovered by conventional imaging, and that early echocardiography may identify those with later pulmonary hypertension.

Conditions

Interventions

TypeNameDescription
OTHEREchocardiographyDiagnostic test which uses ultrasound waves to make images of the heart chambers, valves and surrounding structures

Timeline

Start date
2019-10-12
Primary completion
2023-11-30
Completion
2025-12-01
First posted
2019-10-03
Last updated
2025-06-17

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04114435. Inclusion in this directory is not an endorsement.